Caribou Biosciences, Inc.CRBUNASDAQ

Revenue (LTM)

$11M

+11.7% YoY

Net Income (LTM)

$-148M

+0.7% YoY

Free Cash Flow

$-112M

Revenue CAGR (5Y)

+3.8%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	10	14↑44.3%	34↑148.9%	10↓71.0%	11↑11.7%
Gross Profit	9	10↑18.5%	31↑203.2%	6↓80.4%	8↑23.9%
Operating Income	-67	-106↓58.9%	-116↓9.1%	-167↓43.6%	-136↑18.3%
Net Income	-67	-99↓48.6%	-102↓2.7%	-149↓46.1%	-148↑0.7%
EBITDA	-66	-96↓45.9%	-113↓17.6%	-163↓44.6%	-133↑18.5%
EPS Diluted	-1.11	-1.64↓47.7%	-1.38↑15.9%	-1.65↓19.6%	-1.59↑3.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	240	58↓75.7%	51↓12.3%	16↓68.2%	12↓24.1%
Total Current Assets	391	260↓33.5%	339↑30.2%	219↓35.3%	145↓33.8%
Total Assets	442	374↓15.5%	432↑15.6%	313↓27.5%	175↓44.0%
Total Current Liabilities	26	28↑8.9%	28↑0.6%	31↑8.3%	25↓17.1%
Total Liabilities	55	73↑33.7%	64↓12.5%	60↓5.4%	53↓11.9%
Total Equity	388	301↓22.4%	368↑22.4%	253↓31.3%	122↓51.7%
Total Debt	0	28↑10612.7%	27↓2.3%	26↓2.3%	27↑2.8%
Net Debt	-240	-31↑87.3%	-24↑21.4%	10↑142.4%	15↑45.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-33	-91↓179.7%	-93↓2.6%	-138↓48.1%	-111↑19.7%
Capital Expenditure	-3	-6↓106.8%	-12↓79.9%	-7↑44.0%	-1↑79.1%
Free Cash Flow	-36	-97↓173.3%	-105↓7.7%	-145↓37.9%	-112↑22.4%
Stock-Based Comp	3	0	14	17↑21.5%	13↓24.1%
Net Change in Cash	225	-182↓181.1%	-7↑96.1%	-35↓385.9%	-4↑88.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance